Diabetes

Top news of the day from across the health care landscape.

Chronic diseases in the United States have a tremendous economic burden. Thirty-four percent of the economic burden of diabetes is attributed to the privately insured population.

Allergan plans to acquire Motus Therapeutics and relamorelin, an investigational drug to treat diabetic gastroparesis.

In a recent study, investigators found that the application of a topical gel that contains the gene heat shock protein 60 significantly increased wound healing in a mouse model of diabetes.

Beneficial results seen when switching to a HIV regimen including Odefsey.

Despite individuals with diabetes having a higher risk of developing serious eye diseases, more than half skip out on their annual eye exams.

Sight-saving eye exam skipped by diabetes patients, despite increased risk of serious eye diseases.

Top news of the day from across the health care landscape.

Although any amount of exercise is beneficial, exceeding the recommended level produces the most benefits for diabetes patients.

One of the most enduring lessons from my training in the care of geriatric patients is the following maxim: “Treat every new symptom like a (possible) drug adverse effect until proven otherwise.”

Inhibiting a specific protein can increase fat breakdown and prevent insulin resistance.

More than 86 million Americans over the age of 20 have prediabetes, 29 million Americans are diagnosed with diabetes, and another 8.1 million Americans are living with undiagnosed diabetes.

Patients with type 2 diabetes eventually need insulin therapy as their disease progresses. The American Diabetes Association recommends basal-only therapy initially, with the addition of bolus meal-time insulin as needed. However, recent research supports starting patients on combined basal-bolus regimens to control blood sugar regardless of added hypoglycemia risk.

By 2025, 268 million children worldwide may be overweight.

Clinicians rely on a limited number of drugs to help patients with type 2 diabetes.

For decades, clinicians relied on a limited number of drugs, including sulfonylureas and metformin, to help patients with type 2 diabetes. However, in the past 20 years, an increasing number of glucose-lowering drugs for diabetes treatment have become available.

Heart failure patients are much more likely to have diabetes than the general population.

The incidence of heart failure is increasing as the world's population ages and the rates of other, often comorbid, diseases (eg, diabetes, heart disease, obesity) increase.

This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.

The number of individuals living with diabetes worldwide significantly increased between 1980 and 2014.

Patients with T2D who get the flu shot may have a reduced risk for hospitalization related to cardiovascular or respiratory issues.

All evidence points to metformin as the first-line oral diabetes treatment for patients with T2D, but research indicates that clinicians often fail to prescribe it when indicated.

T cell subset may play a crucial role in the development of diabetes.

Insulin therapy must be individualized and balanced with meal planning and exercise.

Insulin therapy must be individualized and balanced with meal planning and exercise.